Estonia 
Semetron, in co-operation with device manufacturer Siemens Healthineers, offers the most innovative solution for acute myocardial infarction (AMI) diagnostics – the Atellica® VTL. The device is able to determine high-sensitivity troponin I levels in capillary whole blood in a near-patient setting in just 8 minutes. The Atellica® VTLi wireless device can be easily integrated into the workflow of hospitals and clinics. The new solution will help streamline primary diagnostics in overcrowded emergency care centres.
